We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




New Technology Improves Aortic Valve Replacement Options

By HospiMedica International staff writers
Posted on 27 Apr 2016
Print article
Image: The SJM Trifecta valve with Glide Technology (Photo courtesy of St. Jude Medical).
Image: The SJM Trifecta valve with Glide Technology (Photo courtesy of St. Jude Medical).
Innovative tissue aortic valve delivery technology improves implantation during both minimally invasive and conventional valve replacement procedures.

The Trifecta aortic valve with Glide Technology (GT) is intended for the treatment of diseased, damaged, or malfunctioning aortic heart valves, with enhanced valve delivery easing implantation in challenging anatomies and surgical approaches, while retaining optimal hemodynamic performance. To reduce wear and deterioration over time, the Trifecta GT valve stent is covered with tissue that improves tissue-to-tissue contact when the leaflets open and close. Additionally, the valve is treated with a proprietary anti-calcification treatment to reduce tissue mineralization.

The valve leaflets are made of bovine pericardium, overlaid on a fatigue-resistant, radiopaque titanium stent that provides a supportive frame for added durability. The stent covering and valve-sewing cuff are made of polyester, and the tissue stent covering is made of porcine pericardium. The Trifecta aortic valve with Glide Technologyis a product of St. Jude Medical (SJM; St. Paul, MN, USA), and has received the European Community CE mark of approval.

“For years, St. Jude Medical has dedicated significant resources to develop best-in-class heart valve replacement options while refining our devices based on physician feedback and clinical outcomes,” said Philip Ebeling, VP and chief technology officer at SJM. “The improved design of the Trifecta GT tissue valve allows for smoother placement while providing nearly unobstructed blood flow over the life of the valve. The Trifecta GT tissue valve is a true testament to our commitment to the cardiac surgery community and the patients they treat.”

“The excellent hemodynamic performance of the valve improves quality of life by restoring blood flow both at rest and during exercise, making it an outstanding choice for a wide range of patients,” said Professor Alain Leguerrier, MD, of Centre Hospitalier Universitaire de Rennes (France). “The enhancements to the Trifecta GT tissue valve facilitate improved valve parachuting and seating, which means the valve can gently glide into place.”

Aortic valve disease results in dysfunction of the aortic valve, usually as a result of stenosis, which can result in narrowing of the valve opening and a reduction in blood flow. Aortic stenosis is a common problem affecting approximately three percent of the population over age 65, and five percent of people older than 75. From the onset of aortic stenosis symptoms, the average survival rate is 50% at two years and 20% at five years.

Related Links:
St. Jude Medical
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Multipurpose Gynecological Table
Dixion Grace 8400

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.